Otto-von-Guericke-Universität Magdeburg

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages (2022) Zeller T, Lutz S, Münnich IA, Windisch R, Hilger P, Herold T, Tahiri N, et al. Journal article Clinical Outcome and Quality of Life of Multimodal Treatment of Extracranial Arteriovenous Malformations: The APOLLON Study Protocol (2022) Schmidt VF, Masthoff M, Vielsmeier V, Seebauer CT, Cangir O, Meyer L, Muekke A, et al. Journal article LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis (2022) Leyh C, Heucke N, Schotten C, Büchter M, Bechmann LP, Wichert M, Dechêne A, et al. Journal article Polyethylenimine Increases Antibacterial Efficiency of Chlorophyllin (2022) Akif FA, Mahmoud M, Prasad B, Richter P, Azizullah A, Qasim M, Anees M, et al. Journal article The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients (2022) Goni E, Tammer I, Schütte K, Thon C, Jechorek D, Mahajan UM, Vasapolli R, et al. Journal article CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges (2022) Biebach L, Cindric S, Koenig J, Aprea I, Dougherty G, Raidt J, Bracht D, et al. Conference contribution eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma (2022) Wang X, Gharahkhani P, Levine DM, Fitzgerald RC, Gockel I, Corley DA, Risch HA, et al. Journal article Dual immune checkpoint blockade of LILRB1 and CD47 enhances antibody-dependent cellular phagocytosis of lymphoma cells by CD20 antibodies (2022) Zeller T, Lutz S, Muennich IA, Windisch R, Hilger P, Herold T, Tahiri N, et al. Conference contribution Mutations in CFAP74 as a cause of primary ciliary dyskinesia (PCD) with normal nasal NO production rate and normal ciliary ultrastructure (2022) Biebach L, Cindric S, Koenig J, Aprea , Dougherty G, Raidt J, Bracht D, et al. Conference contribution CAR T Cell Treatment of Refractory Systemic Lupus Erythematosus (2022) Schett G, Böltz S, Müller F, Kleyer A, Völkl S, Aigner M, Gary R, et al. Conference contribution